Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: Double blind randomised controlled study

British Medical Journal

Volumn 327, Issue 7409, 2003, Pages 251-254

  Radcliffe, Michael J ^a   Lewith, George T ^a   Turner, Richard G ^b   Prescott, Philip ^a   Church, Martin K ^a   Holgate, Stephen T ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; BETA GLUCURONIDASE; CYCLOHEXANE 1,3 DIOL; CYCLOHEXANE DERIVATIVE; PLACEBO; PROTAMINE SULFATE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DANDER; DESENSITIZATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DUST; FEMALE; FUNGUS SPORE; GRASS POLLEN; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MITE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; RISK FACTOR; SEASONAL VARIATION; SKIN TEST; SUMMER; SYMPTOMATOLOGY; TREATMENT PLANNING; TREE; WEED;

EID: 0041627875     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7409.251     Document Type: Article

References (14)

1. Bousquet J, Lockey RF, Malling H-J. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(suppl 44):1-42.
2. Durham SR, Walker SM, Varga EM, Jacobsen MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-75.
3. Committee on Safety of Medicines. CSM update: desensitising vaccines. BMJ 1986;293:948.
4. Fell P, Brostoff J. Single dose desensitisation for summer hay fever. Eur J Clin Pharmacol 1990;38:77-9.
5. McEwen LM. Enzyme-potentiated hyposensitization: effects of glucose, glucosaminc, N-acetylamino-sugars and gelatin on the ability of β-glucuronidase to block the anamnestic response to antigen in mice. Ann Allergy 1973;31:79-83.
6. McEwen LM, Nicholson, M. Kitchen I, White S. Enzyme-potentiated hyposensitization: III control by sugars and diols of the immunological effect of beta glucuronidase in mice and patients with hay fever. Ann Allergy 1973;31:543-50.
7. Longo G, Poli F, Bertoli G. Efficacia clinica di un nuovo trattemento iposensibilizzante, EPD (enzyme potentiated desensitisation) nella terapia della pollinosi. Reforma Medica 1992;107:171-6.
8. Di Stanislao C, Di Berardino L, Bianchi I, Bologna G. A double-blind, placebo-controlled study of preventive immunotherapy with EPD, in the treatment of seasonal allergic disease. Allerg Immunol (Paris) 1997;29:39-42.
9. Astarita C, Scala, G, Sproviero S, Franzese A. Effects of enzyme-potentiated desensitisation in the treatment of pollinosis: a double-blind placebo-controlled trial. J Invest Allergol Clin Immunol 1996;6:248-55.
10. Angelini G, Curatoli G, D'Argento V, Vena GA. Pollinosis: una nuova metodica di immunoterapia. Medit J Surg Med 1993:253-6.
11. Caramia G, Franceschini F, Cimarelli ZA, Ciucchi MS, Gagliardini R, Ruffini E. The efficacy of EPD, a new immunotherapy, in the treatment of allergic diseases in children. Allerg Immunol (Paris) 1996;28:308-10.
12. Malling H-J. Proposed guidelines for quantitative skin prick test procedures to determine the biological activity of allergenic extracts using parallel line assay. Allergy 1987;42:391-4.
13. Möller C, Björkstén B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984;39:37-41.
14. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy 2000;30:132-40.